Seroatlas · Human Serome Atlas

SLC16A12

Monocarboxylate transporter 12

Also known as: MCT12, MOT12_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q6ZSM3
Gene
SLC16A12
Ensembl
ENSG00000152779
Chromosome
10
Canonical length
516 aa
Protein class
Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters

OverviewNCBI Gene

This gene encodes a transmembrane transporter that likely plays a role in monocarboxylic acid transport. A mutation in this gene has been associated with juvenile cataracts with microcornea and renal glucosuria. [provided by RefSeq, Mar 2010]

Canonical amino-acid sequenceUniProt

516 residues, UniProt reviewed canonical sequence.

>Q6ZSM3|SLC16A12
     1  MPSGSHWTAN SSKIITWLLE QPGKEEKRKT MAKVNRARST SPPDGGWGWM IVAGCFLVTI
    61  CTRAVTRCIS IFFVEFQTYF TQDYAQTAWI HSIVDCVTML CAPLGSVVSN HLSCQVGIML
   121  GGLLASTGLI LSSFATSLKH LYLTLGVLTG LGFALCYSPA IAMVGKYFSR RKALAYGIAM
   181  SGSGIGTFIL APVVQLLIEQ FSWRGALLIL GGFVLNLCVC GALMRPITLK EDHTTPEQNH
   241  VCRTQKEDIK RVSPYSSLTK EWAQTCLCCC LQQEYSFLLM SDFVVLAVSV LFMAYGCSPL
   301  FVYLVPYALS VGVSHQQAAF LMSILGVIDI IGNITFGWLT DRRCLKNYQY VCYLFAVGMD
   361  GLCYLCLPML QSLPLLVPFS CTFGYFDGAY VTLIPVVTTE IVGTTSLSSA LGVVYFLHAV
   421  PYLVSPPIAG RLVDTTGSYT AAFLLCGFSM IFSSVLLGFA RLIKRMRKTQ LQFIAKESDP
   481  KLQLWTNGSV AYSVARELDQ KHGEPVATAV PGYSLT

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against SLC16A12 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
12
Mean surface accessibility (rSASA)
0.29
Highest tissue expression
79 nTPM

Expression across tissuesHPA

Tissue

  • kidney: 79 nTPM
  • choroid plexus: 56 nTPM
  • epididymis: 49 nTPM
  • pancreas: 24 nTPM
  • seminal vesicle: 13 nTPM
  • placenta: 11 nTPM

Single-cell type

  • proximal tubule cells: 1,235 nCPM
  • choroid plexus epithelial cells: 589 nCPM
  • loop of henle epithelial cells: 504 nCPM
  • retinal pigment epithelial cells: 418 nCPM
  • epididymal principal cells: 150 nCPM
  • leydig cells: 140 nCPM

Immune cell

  • basophil: 0.3 nTPM
  • NK-cell: 0.1 nTPM
  • classical monocyte: 0 nTPM
  • eosinophil: 0 nTPM
  • gdT-cell: 0 nTPM
  • intermediate monocyte: 0 nTPM

Brain region

  • choroid plexus: 194 nTPM
  • hippocampal formation: 6.6 nTPM
  • cerebral cortex: 6.3 nTPM
  • midbrain: 4.1 nTPM
  • spinal cord: 3.3 nTPM
  • basal ganglia: 3.2 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about SLC16A12.

Disease | AllUniProt

Conditions SLC16A12 is implicated in, by any mechanism.

Disease | GeneticClinVar

3 pathogenic / likely-pathogenic of 146 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.48
gnomAD pLI
0.49
gnomAD missense Z
0.95
DepMap mean gene effect
-0.11
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 0% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of SLC16A12 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads SLC16A12 as an antibody target. Whether an autoantibody or antibody against SLC16A12 could matter depends on whether native SLC16A12 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

SLC16A12 is annotated at the cell surface, where native SLC16A12 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label SLC16A12 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/SLC16A12. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...